Short communication: Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?

Simple item page
dc.FacultyEndemic Diseasesen_US
dc.contributor.authorElhassan, Ahmed M.
dc.contributor.authorkalil, Eltahir Awad G.
dc.contributor.otherClinical Pathology and Immunologyen_US
dc.date2001
dc.date.accessioned2015-12-08T08:43:59Z
dc.date.available2015-12-08T08:43:59Z
dc.date.issued2015-12-08
dc.date.submitted2015-12-08
dc.description.abstractIn 1997 a sudden outbreak of visceral leishmaniasis (VL) occurred in eastern Sudan, coinciding with an increase of post-kala-azar dermal leishmaniasis (PKDL) cases which may in part be because of sylvatic and anthroponotic transmission. Paradoxically, the more VL patients are treated, the higher the frequency of PKDL. If PKDL plays a role in transmission, its treatment would be expected to reduce infection in the area. Treatment of PKDL, however, requires four times the amount of Pentostam used for treating VL, and the drug is both expensive and in short supplyen_US
dc.identifier.urihttp://khartoumspace.uofk.edu/handle/123456789/17464
dc.publisherUOFKen_US
dc.subjectpost-kala-azar leishmaniasisen_US
dc.subjectvisceral leishmaniasisen_US
dc.subjectsodium stibogluconateen_US
dc.subjectSudanen_US
dc.titleShort communication: Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?en_US
dc.typeArticleen_US

Files

Collections

Medical and Health
Load more